Azithromycin for Child Survival in Niger II

PHASE4RecruitingINTERVENTIONAL
Enrollment

3,300,000

Participants

Timeline

Start Date

April 29, 2024

Primary Completion Date

April 29, 2028

Study Completion Date

April 29, 2028

Conditions
MortalityAntimicrobial Resistance
Interventions
DRUG

Azithromycin for Oral Suspension

Azithromycin will be administered as a single dose, in oral suspension form for children. The dose will be calculated by age or height depending on the child's age Both dosing cups and syringes will be used to administer treatment. For children too young to drink out of a dosing cup, a 1 ml or 5 ml syringe will be used, and the calculated dose will be rounded upwards to the nearest 0.2 ml.

Trial Locations (1)

Unknown

RECRUITING

Program National de Santé Oculaire, Niamey

All Listed Sponsors
collaborator

Centre de recherche et interventions en santé publique (CRISP)

UNKNOWN

collaborator

Ministère de la Santé Publique du Niger

UNKNOWN

collaborator

Le Programme National de Santé Oculaire

UNKNOWN

collaborator

Centre de Recherche Médicale et Sanitaire

OTHER

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of California, San Francisco

OTHER